Pursuant to Regulation 29 of the Listing Regulations, Ajanta Pharma has informed that a Meeting of the Board of Directors of the Company will be held on Wednesday, 9th August, 2017 at the Registered Office of the Company at Ajanta House, Charkop, Kandivli (West), Mumbai - 400 067, to consider and approve the Unaudited consolidated and standalone Financial Results of the Company for the first quarter ended 30th June, 2017. Further, pursuant to the Ajanta’s Code of Conduct for of Insiders, the Trading Window for dealing in the shares of the Company shall remain closed for the Designated persons, from the close of business hours of Monday, 31st July, 2017. The trading window will open 48 hours after the announcement of results.
The above information is a part of company’s filings submitted to BSE.
